Clinical Trial Update: SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases

View source ↗

Summary

Clinical trial update about SMYD3-driven metabolic changes in colorectal cancer with liver metastases; trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Liver Metastases

Snippet

Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | Conditions: CRC (Colorectal Cancer), Liver Metastases From Colorectal Primary Cancer | Status: NOT_YET_RECRUITING